Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department

James L. Januzzi, Rahul Sakhuja, Michelle O'Donoghue, Aaron L. Baggish, Saif Anwaruddin, Claudia U. Chae, Renee Cameron, Daniel G. Krauser, Roderick Tung, Carlos A. Camargo, Donald M. Lloyd-Jones

Research output: Contribution to journalArticlepeer-review

220 Scopus citations

Abstract

Background: Amino-terminal pro-brain natriuretic peptide (NT-proBNP) is useful for diagnosis and triage of patients with dyspnea, but its role for predicting outcomes in such patients remains undefined. Methods: A total of 599 breathless patients treated in the emergency department were prospectively enrolled, and a sample of blood was obtained for NT-proBNP measurements. After 1 year, the vital status of each patient was ascertained, and the association between NTproBNP values at presentation and mortality was assessed. Results: At 1 year, 91 patients (15.2%) had died. Median NT-proBNP concentrations at presentation among decedents were significantly higher than those of survivors (3277 vs 299 pg/mL; P<.001). The optimal NTproBNP cut point for predicting 1-year mortality was 986 pg/mL. In a multivariable model, an NT-proBNP concentration greater than 986 pg/mL at presentation was the single strongest predictor of death at 1 year (hazard ratio [HR], 2.88; 95% confidence interval, 1.64-5.06; P<.001), independent of a diagnosis of heart failure. Other factors associated with death included age (by decade; HR,1.20), heart rate (by decile; HR,1.13), urea nitrogen level (by decile; HR,1.20), systolic blood pressure less than 100 mm Hg (HR, 1.94), heart murmur (HR,1.92), and New York Heart Association classification (HR,1.38 for each increase in class). The NT-proBNP concentration alone had an area under the receiver operating characteristic curve (AUC) of 0.76 for predicting mortality; the other significant covariates combined had an AUC of 0.80. The final model for predicting death, combining NT-proBNP with other covariates associated with mortality, had a superior AUC of 0.82. Conclusion: In addition to assisting in emergency department diagnosis and triage, NT-proBNP concentrations at presentation are strongly predictive of 1-year mortality in dyspneic patients.

Original languageEnglish (US)
Pages (from-to)315-320
Number of pages6
JournalArchives of internal medicine
Volume166
Issue number3
DOIs
StatePublished - Feb 13 2006
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department'. Together they form a unique fingerprint.

Cite this